share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ambrose Kristen

SEC announcement ·  Feb 27 16:39
Summary by Moomoo AI
Kristen Ambrose, SVP & Chief Accounting Officer of Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 1,711 shares of common stock over two transactions dated February 23 and 26, 2024. The first transaction on February 23 involved the disposal of 828 shares at a price of $431.79 per share, while the second on February 26 saw 883 shares sold at $425.7 each. Following these transactions, Ambrose's direct holdings in the company amount to 7,965 shares. The total market value of the disposed shares is calculated to be approximately $733,415.22.
Kristen Ambrose, SVP & Chief Accounting Officer of Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 1,711 shares of common stock over two transactions dated February 23 and 26, 2024. The first transaction on February 23 involved the disposal of 828 shares at a price of $431.79 per share, while the second on February 26 saw 883 shares sold at $425.7 each. Following these transactions, Ambrose's direct holdings in the company amount to 7,965 shares. The total market value of the disposed shares is calculated to be approximately $733,415.22.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more